(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HUNTSMAN CANCER HOSPITAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HUNTSMAN CANCER HOSPITAL

ST13

US500000085080798

Class

44

Filing

85080798

Registration

4148523

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

04/30/2026

Classification

Registered

Trademark type

Word

Nice classes

44

Filing date

07/08/2010

Registration date

05/29/2012

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/07/2022

Last transaction

04/30/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

07/01/2004

First use in commerce

07/01/2004

Drawing code

4

Owner type

99

Owner location

Salt Lake City, UT, US

Examiner

SHARPER JR, SAM

Law office

L80

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

T. U. (pessoa física)

Representatives

Lester K. Essig Ray Quinney & Nebeker

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical services; medical testing for diagnostic and treatment purposes in the field of cancer; medical diagnostic reporting services; health care services; hospital services for persons with cancer; clinical medical test servicesconducting clinical trials; medical imaging services; medical radiology services; medical chemotherapy services; surgery services; providing medical servicesmedical testing for diagnostic and treatment purposes; providing medical servicesmedical testing for diagnostic and treatment purposes for the uninsured and underinsured; medical recovery services; medical rehabilitation servicesphysical rehabilitation and rehabilitation patient care services; providing medical services in the fields of geneticscancercancer diagnosiscancer preventioncancer treatmentcancer patient and family support; preparation and dispensing of medications; providing medical information and consultation in the fields of medicinegeneticscancercancer awarenesscancer testingcancer diagnosiscancer preventioncancer treatmentvolunteer programspatient reportscancer patient and family support; on-line medical information services in the fields of medicinegeneticscancercancer awarenesscancer testingcancer diagnosiscancer preventioncancer treatmentvolunteer programspatient reportscancer patient and family support

Publications

History of USPTO decisions and trademark events.

41 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/28/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/28/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/28/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/28/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/07/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/07/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/07/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/05/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

05/23/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/29/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/30/2019

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/30/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/23/2019

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

01/17/2019

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

07/17/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/06/2018

E815

TEAS SECTION 8 & 15 RECEIVED

05/29/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

05/29/2012

PUBO

PUBLISHED FOR OPPOSITION

03/13/2012

NPUB

NOTICE OF PUBLICATION

02/22/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/08/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/07/2012

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/27/2012

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

01/17/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/03/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/03/2012

ACEC

AMENDMENT FROM APPLICANT ENTERED

12/13/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/13/2011

MAIL

PAPER RECEIVED

12/05/2011

CNFR

FINAL REFUSAL MAILED

06/03/2011

CNFR

FINAL REFUSAL WRITTEN

06/02/2011

ACEC

AMENDMENT FROM APPLICANT ENTERED

05/12/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/12/2011

ALIE

ASSIGNED TO LIE

05/05/2011

MAIL

PAPER RECEIVED

04/29/2011

CNRT

NON-FINAL ACTION MAILED

10/27/2010

CNRT

NON-FINAL ACTION WRITTEN

10/27/2010

DOCK

ASSIGNED TO EXAMINER

10/20/2010

MPMK

NOTICE OF PSEUDO MARK MAILED

07/14/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2010

NWAP

NEW APPLICATION ENTERED

07/12/2010

Continuous trademark protection

Get notified about every new filing that threatens HUNTSMAN CANCER HOSPITAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.